The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
There was a significant amount of turnover this year in the corner offices of medical device companies, including exits by some of medtech's biggest names.
There was a revolving door on medtech's corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.
Here's a look at some of the top legal news stories for medical device companies this week: Lawyer says Guidant didn't breach deal with J&J; Ex-Abbott stent liaison alleges retaliation for compliance complaint; Trial date set for Boston Scientific executive's accused killer; Analogic expects fines in BK Medical's Danish bribery beef; SEC dings Bruker in $2.4m China bribery case